Post Categories
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
March 26, 2019
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28…
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
March 26, 2019
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the…
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific…
Translational Medicine Now Bigger and Better at QPS
July 14, 2017
Goodbye boutique CRO, hello large study BIG PLAYER! For a long time, you’ve known us as THE high quality outfit that can stabilize difficult…
QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference
June 12, 2017
The 2017 Transdermal & Intradermal Drug Delivery Systems conference covering Advanced Design, Development & Delivery of Skin-Mediated Therapies and Vaccines is coming up on…
QPS Tapped for Two New FIH Studies
May 5, 2017
Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute…
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
May 2, 2017
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels…
QPS Sponsors Day 1 of World ADC Meeting in Berlin
February 20, 2017
QPS is the main sponsor of the Analytical and Bioanalytical Day at the 7th World ADC Meeting, February 20 – 22, 2017 at the…
QPS Assay Finder Database Grows 47 New Assays!
November 28, 2016
For all you assay aficionados out there, we thought you’d be juiced to know — we just added a whopping 47 new assays to…
Client Feedback — Our Gold Standard
December 13, 2016
At QPS, we love making customers happy. Here’s what two of them had to say about our work in DMPK protein binding studies: First…
QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year
December 5, 2016
For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and…
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics,…
The Resurgence of Strep A and the Effects of the COVID-19 Pandemic
January 30, 2023
An unexpected increase in cases of streptococcal A (strep A) infection in the United Kingdom is troubling for families, healthcare practitioners, and researchers. Although…
Pigs Could Solve the Organ Transplant Crisis
January 25, 2023
2022 held a number of significant breakthroughs in researchers’ ongoing efforts to solve the organ transplant crisis. Many of those breakthroughs were in xenotransplantation,…
The Unlikely Role of Hops in the Prevention of Alzheimer’s Disease
January 23, 2023
A team of Italian scientists from the University of Milan-Bicocca have recently discovered a possible use of hops, the flowers used to enhance both…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
A Breakthrough in Converting Brain Waves to Speech
January 11, 2023
A new pilot study conducted by Chang Lab at UC San Francisco has demonstrated the ability to use new neurotechnology to enable paralyzed individuals…
The Modern Quest for the Fountain of Youth
January 9, 2023
Quests for anti-aging solutions, usually the stuff of science fiction, have been revived with research into cellular reprogramming. More than 15 years ago, researchers…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…